Gestational diabetes guidelines in a HAPO world

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 4, 2010, Pages 673-685

  Leary, Joyce ^a   Pettitt, David J ^b   Jovanovič, Lois ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Diabetes; Diabetes mellitus; Diabetes Mellitus; Gestational; Gestational Diabetes; Gestational Diabetes Mellitus; Glucose intolerance; Hyperglycemia; Insulin resistance; Pregnancy Induced; Pregnancy Induced Diabetes

Indexed keywords

C PEPTIDE; GLUCOSE;

BIRTH WEIGHT; COST EFFECTIVENESS ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEALTH CARE COST; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; IMPAIRED FASTING GLUCOSE; INSULIN RESISTANCE; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SCREENING; COST BENEFIT ANALYSIS; ECONOMICS; GLUCOSE TOLERANCE TEST; MASS SCREENING; PREGNANCY;

COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 79952118078     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2010.05.009     Document Type: Review

References (61)

1. Hoffman L, Nolan C, Wilson JD, Oats JJ & Simmons D. Gestational diabetes mellitusdmanagement guidelines. The Australasian Daibetes in Pregnancy Society. Med J Aust 1998; 169: 92-97.
2. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: WHO Document Production Services, 1999. pp 19-20.
3. American College of Obstetricians and Gynecologists Committee on Practice BulletinsdObstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001. (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98(3): 525-538.
4. Berger H, Crane J, Farine D, Armson A, De La Ronde S, Keenan-Lindsay L et al. Screening for gestational diabetes mellitus. J Obstet Gynaecol Can 2002; 24(11): 894-912.
5. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002; 55(1): 65-85. (Pubitemid 34036538)
6. Per Kautzky-Willer A, Bancher-Todesca D & Birnbacher R. Gestational diabetes mellitus [in German]. Acta Medica Austriaca 2004; 31: 182-184.
7. Joslin Diabetes Center and Joslin Clinic guideline for detection and management of diabetes in pregnancy. www.joslin.org/docs/Gest-guide.pdf. Joslin Diabetes Center. 2005.
8. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus: screening and diagnosis. Endocr Prac 2007; 13 (Suppl 1): 10-12.
9. Metzger B, Buchanan T, Coustan D, de Leiva A, Dunger DB, Hadden DR et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 2007; 30(S2): S251-S260. (Pubitemid 47036434)
10. Sociedad Brasileira de Endocrinologia e Metabologia. Diabetes mellitus gestacional. Rev Assoc Med Bas 2008; 54(6): 477-480.
11. The Hong Kong College of Obstetricians and Gynaecologists. Guidelines for the management of gestational diabetes mellitus part 1dscreening and diagnosis. HKCOG Guidelines 2008; 7: 1-10.
12. U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148(10): 759-765.
13. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 2008; 336(7646): 714-717.
14. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33(Suppl 1): S62-S69.
15. O'Sullivan JB & Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278-285.
16. International Association of Diabetes and Pregnancy Study Groups. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33 (3): 676-682.
17. Bevier WC, Fischer R & Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999; 16(6): 269-275.
18. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS & Robinson JS. Australian Carbohydrate Intolerance Study in PregnantWomen (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352(24): 2477-2486. (Pubitemid 41007863)
19. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361(14): 1339-1348.
20. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 1991-2002; 2008: 358.
21. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with neonatal anthropometrics. Diabetes 2009; 58(2): 453-459.
22. Pettitt DJ, Knowler WC, Baird HR & Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980; 3(3): 458-464. (Pubitemid 10000695)
23. Jovanovic L & Peterson CM. Screening for gestational diabetes: optimum timing and criteria for retesting. Diabetes 1985; 34(Suppl 2): 21-23. (Pubitemid 15044182)
24. Davey RX & Hamblin PS. Selective versus universal screening for gestational diabetes mellitus: an evaluation of predictive risk factors. Med J Aust 2001; 174(3): 118-121. (Pubitemid 32149355)
25. Naylor CD, Sermer M, Chen E & Farine D. Selective Screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997; 337(22): 1591-1596.
26. van Leeuwen M, Opmeer BC, Zweers EJ, van Ballegooie E, ter Brugge HG, de Valk HW et al. External validation of a clinical scoring system for the risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2009; 85(1): 96-101.
27. Minsart AF, Lescrainier JP & Vokaer A. Selective versus universal screening for gestational diabetes mellitus: an evaluation of Naylor's model. Gynecol Obstet Invest 2009; 68(3): 154-159.
28. Weeks JW, Major CA, de Veciana M & Morgan MA. Gestational diabetes: does the presence of risk factors influence perinatal outcome? Am J Obstet Gynecol 1994; 171(4): 1003-1007. (Pubitemid 24341486)
29. Moses RG & Cheung NW. Point: universal screening for gestational diabetes mellitus. Diabetes Care 2009; 32(7): 1349-1351.
30. Cosson E, Benchimol M, Carbillon L, Pharisien I, Pariès J, Valensi P et al. Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabetes Metab 2006; 32(2): 140-146.
31. Griffin ME, Coffey M, Johnson H, Scanlon P, Foley M, Stronge J et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med 2000; 17(1): 26-32. (Pubitemid 30094177)
32. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S88-S90.
33. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynaecol Obstet 2002; 78(1): 69-77.
34. WHO Expert Committee on Diabetes Mellitus. second report. WHO Technical Report Series, No. 1980; 646.
35. Metzger BE & Coustan DR. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1998; 21(Suppl 2): B161-B167. (Pubitemid 28357050)
36. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa e Forti A et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24(7): 1151-1155. (Pubitemid 33716390)
37. Pettitt DJ, Bennett PH, Hanson RL & Narayan KM. Knowler WCl. Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care 1994; 17 (11): 1264-1268.
38. Sacks DA, Greenspoon JS, Abu-Fadil S, Henry HM, Wolde-Tsadik G & Yao JF. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 1995; 172(2): 607-614.
39. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation 2006.
40. Weiss PA, Haeusler M, Tamussino K & Hass J. Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107(12): 1480-1485. (Pubitemid 32047479)
41. Mello G, Parretti E, Cioni R, Lucchetti R, Carignani L, Martini E et al. The 75-gram glucose load in pregnancy: relation between glucose levels and anthropometric characteristics of infants born to women with normal glucose metabolism. Diabetes Care 2003; 26(4): 1206-1210. (Pubitemid 36929273)
42. Sermer M, Naylor CD, Farine D, Kenshole AB, Ritchie JW, Gare DJ et al. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998; 21(Suppl 2): B33-B42. (Pubitemid 28357030)
43. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M & Langer O. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 2004; 191(3): 949-953. (Pubitemid 39298139)
44. Parretti E, Mecacci F, Papini M, Cioni R, Carignani L, Mignosa M et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care 2001; 24(8): 1319-1323. (Pubitemid 33716414)
45. World Health Organization Study Group. Diabetes mellitus. Technical Report Series 1985; 727: 13.
46. International Diabetes Federation: Diabetes Atlas 2006. 3rd edn, Brussels, International Diabetes Federation, 2006.
47. Hunt KJ & Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007; 34(2): 173-199. (Pubitemid 46891746)
48. Moses RG. New consensus criteria for GDM: problem solved or Pandora's box? Diabetes Care 2010; 33(3): 690-691.
49. Jovanovic-Peterson L, Bevier W & Peterson CM. The Santa Barbara County Health Care Services Program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention? Am J of Perinatol 1997; 14(4): 221-228. (Pubitemid 27188415)
50. Kitzmiller JL, Elixhauser A, Carr S, Major CA, de Veciana M, Dang-Kilduff L et al. Assessment of costs and benefits of management of gestational diabetes mellitus. Diabetes Care 1998; 21(Suppl 2): B123-B130. (Pubitemid 28357044)
51. Scott DA, Loveman E, McIntyre E & Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 2002; 6(11): 1-161.
52. Moss JR, Crowther CA, Hiller JE, Willson KJ & Robinson JS. Costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth 2007; 7: 27.
53. Wang Y & Beydoun MA. The obesity epidemic in the United Statesdgender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6-28. (Pubitemid 47229643)
54. Jovanovic L. Definition, size of the problem, screening and diagnostic criteria: who should be screened, cost effectiveness, and feasibility of screening. Int J Gynaecol Obstet 2009; 104(Suppl 1): S17-S19.
55. Meltzer SJ, Snyder J, Penrod JR, Nudi M & Morin L. Gestational diabetes mellitus screening and diagnosis: a prospective randomized controlled trial comparing costs of one-step and two-step methods. BJOG 2010; 117(4): 407-415.
56. Lavin Jr. JP, Lavin B & O'Donnell N. A comparison of costs associated with screening for gestational diabetes with two-tiered and one-tiered testing protocols. Am J Obstet Gynecol 2001; 184(3): 363-367. (Pubitemid 32206985)
57. Nicholson WK, Fleisher LA, Fox HE & Powe NR. Screening for gestational diabetes: a decision and cost-effectiveness analysis of four screening strategies. Diabetes Care 2005; 28(6): 1482-1484. (Pubitemid 40756717)
58. Pettitt DJ & Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 1998; 21(Suppl 2): B138-B141. (Pubitemid 28357046)
59. Clausen TD, Matheisen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J et al. High prevalence of type 2 diabetes and prediabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31(2): 340-346. (Pubitemid 351213348)
60. Witkop CT, Neale D, Wilson LM, Bass EB & Nicholson WK. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol 2009; 113(1): 206-217.
61. Pettitt DJ, McKenna S, McLaughlin C, Patterson CC, Hadden DR & McCance DR. Maternal glucose at 28 weeks gestation is not associated with obesity in two year old offspring: the Belfast HAPO Family Study. Diabetes Care 2010; 33: 1219-1223.